Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas

Modern Pathology

Volumn 9, Issue 1, 1996, Pages 1-6

  Mousses, Spyro ^b   McAuley, Laura ^b   Bell, Robert S ^b   Kandel, Rita ^b   Andrulis, Irene L ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

DNA analysis; Immunohistochemistry; p53 gene; Sarcoma; Tumor suppressor

Indexed keywords

PROTEIN P53;

ARTICLE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA;

BONE NEOPLASMS; DNA, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; POLYMORPHISM, GENETIC; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0030060750     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Linzer DIH, Levine AJ: Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43, 1979
2. Lane DP, Crawford LV: T antigen is bound to a host protein in SV40-transformed cells. Nature (London) 278:261, 1979
3. Lane DP, Benchimol S: p53, oncogene or protooncogene? Genes Dev 4:1, 1990
4. Maltzman W, Czyzyk L: UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4:1689, 1984
5. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response of DNA damage. Cancer Res 51:6304, 1991
6. Debbas M, White E: Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev 7:546, 1993
7. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (London) 362:847, 1993
8. Lowe SW, Jacks T, Housman DE, Ruley HE: Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. PNAS 91:2026, 1994
9. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppresson. Cell 75:817, 1993
10. Ozcelik H, Mousses S, Andrulis IL: Low levels of expression of an inhibitor of cyclin-dependent kinases (CI P1/WAF1) in primary breast carcinomas with p53 mutations. Clin Cancer Res 1:907, 1995
11. Harper JW, Adami GR, Wei N, Keyomarsi J, Elledge SJ: The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805, 1993
12. Xiong Y, Hannon GJ, Zhang H, Casson D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature (London) 366:701, 1993
13. El-Deiry WS, Harper JW, O'Conner PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill D, Wang Y, Wilman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kenneth SJ, Kinzler KW, Vogelstein B: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169, 1994
14. Hunter T: Braking the cycle. Cell 75:839, 1993
15. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B: Mutations in the human p53 gene occur in diverse human tumour types. Nature (London) 342:705, 1989
16. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science (Washington, DC) 253:49, 1991
17. Malkin D, Li FP, Strong LC, Fraumeni Jr JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bishoff FZ, Tainsky MA, Friend SH: Germ line p53 mutations in familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington, DC) 250: 1233, 1990
18. Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH: Germ line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndorme. Nature (London) 348:747, 1990
19. Malkin D: p53 and the Li-Fraumeni syndrome. Cancer Genet Cytogenet 66:83, 1993
20. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS, Little JB, Weichselbaum RR, Ishizaki K, Yandell DW: Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52:6194, 1992
21. Andreassen A, Oyjord T, Hovig E, Holm R, Florense VA, Nesland JM, Myklebost O, Hoie J, Bruland OS, Borresen A-L, Fodstad O: p53 abnormalities in different subtypes of human sarcomas. Cancer Res 53:468, 1993
22. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill D, Sidransky D, Kinzler KW, Vogelstein B: p53 mutations and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53:2231, 1993
23. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennam MF, Levine AJ: Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54:794, 1994
24. Momand J, Zambetti GP, Olson DC, George DL, Levine AJ: The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transcription. Cell 69: 1237, 1992
25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guadinium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 162:156, 1987
26. Kovach JS, McGovern RM, Cassady JD, Swanson SK, Wold LE, Vogelstein B, Sommer SS: Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas. J Natl Cancer Inst 83:1004, 1991
27. Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874, 1989
28. Gyllensten UB, Erlich HA: Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci USA 85:7652, 1988
29. Carbone D, Itsuo C, Mitsudomi T: Polymorphism at codon 213 within the p53 gene. Oncogene 6:1691, 1991
30. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Koutoura Y, Yamamuro T: p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 68:1134, 1993